These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 8983348)

  • 1. A comparison of cleavable and noncleavable hydrazinopyridine linkers for the 99mTc labeling of Fab' monoclonal antibody fragments.
    Bridger GJ; Abrams MJ; Padmanabhan S; Gaul F; Larsen S; Henson GW; Schwartz DA; Longley CB; Burton CA; Ultee ME
    Bioconjug Chem; 1996; 7(2):255-64. PubMed ID: 8983348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reagents for astatination of biomolecules. 5. Evaluation of hydrazone linkers in (211)At- and (125)I-labeled closo-decaborate(2-) conjugates of Fab' as a means of decreasing kidney retention.
    Wilbur DS; Chyan MK; Hamlin DK; Nguyen H; Vessella RL
    Bioconjug Chem; 2011 Jun; 22(6):1089-102. PubMed ID: 21513347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor imaging with technetium-99m-labeled hydrazinonicotinamide-Fab' conjugates.
    Ultee ME; Bridger GJ; Abrams MJ; Longley CB; Burton CA; Larsen SK; Henson GW; Padmanabhan S; Gaul FE; Schwartz DA
    J Nucl Med; 1997 Jan; 38(1):133-8. PubMed ID: 8998167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monoclonal antibody Fab' fragment cross-linking using equilibrium transfer alkylation reagents. A strategy for site-specific conjugation of diagnostic and therapeutic agents with F(ab')2 fragments.
    Wilbur DS; Stray JE; Hamlin DK; Curtis DK; Vessella RL
    Bioconjug Chem; 1994; 5(3):220-35. PubMed ID: 7918742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapid infarct imaging with a technetium-99m-labeled antimyosin recombinant single-chain Fv: evaluation in a canine model of acute myocardial infarction.
    Nedelman MA; Shealy DJ; Boulin R; Brunt E; Seasholtz JI; Allen IE; McCartney JE; Warren FD; Oppermann H; Pang RH
    J Nucl Med; 1993 Feb; 34(2):234-41. PubMed ID: 8429342
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreased kidney uptake of technetium-99m-labelled Fab' fragments in ovarian carcinoma bearing nude mice using a cleavable chelator.
    Tibben JG; Massuger LF; Boerman OC; Claessens RA; Borm GF; Pak KY; Koenders EB; Corstens FH
    Nucl Med Biol; 1994 Jan; 21(1):17-24. PubMed ID: 9234260
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    Ahmadpour S; Noaparast Z; Abedi SM; Hosseinimehr SJ
    Anticancer Agents Med Chem; 2018; 18(9):1295-1302. PubMed ID: 29521248
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced kidney clearance with an ester-linked 99mTc-radiolabeled antibody Fab'-chelator conjugate.
    Weber RW; Boutin RH; Nedelman MA; Lister-James J; Dean RT
    Bioconjug Chem; 1990; 1(6):431-7. PubMed ID: 2099189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Site-specific conjugation of bifunctional chelator BAT to mouse IgG1 Fab' fragment.
    Li J; Wang XH; Wang XM; Chen ZL
    Acta Pharmacol Sin; 2006 Feb; 27(2):237-41. PubMed ID: 16412275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor targeting properties of indium-111 labeled genetically engineered Fab' and F(ab')2 constructs of chimeric tumor necrosis treatment (chTNT)-3 antibody.
    Khawli LA; Alauddin MM; Hu P; Epstein AL
    Cancer Biother Radiopharm; 2003 Dec; 18(6):931-40. PubMed ID: 14969605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-linear energy transfer (LET) alpha versus low-LET beta emitters in radioimmunotherapy of solid tumors: therapeutic efficacy and dose-limiting toxicity of 213Bi- versus 90Y-labeled CO17-1A Fab' fragments in a human colonic cancer model.
    Behr TM; Béhé M; Stabin MG; Wehrmann E; Apostolidis C; Molinet R; Strutz F; Fayyazi A; Wieland E; Gratz S; Koch L; Goldenberg DM; Becker W
    Cancer Res; 1999 Jun; 59(11):2635-43. PubMed ID: 10363986
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Control of radioactivity pharmacokinetics of 99mTc-HYNIC-labeled polypeptides derivatized with ternary ligand complexes.
    Ono M; Arano Y; Mukai T; Saga T; Fujioka Y; Ogawa K; Kawashima H; Konishi J; Saji H
    Bioconjug Chem; 2002; 13(3):491-501. PubMed ID: 12009938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparation, characterization, and in vivo biodistribution properties of synthetically cross-linked multivalent antitumor antibody fragments.
    Schott ME; Frazier KA; Pollock DK; Verbanac KM
    Bioconjug Chem; 1993; 4(2):153-65. PubMed ID: 7873647
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pretargeting for cancer radioimmunotherapy with bispecific antibodies: role of the bispecific antibody's valency for the tumor target antigen.
    Karacay H; Sharkey RM; McBride WJ; Griffiths GL; Qu Z; Chang K; Hansen HJ; Goldenberg DM
    Bioconjug Chem; 2002; 13(5):1054-70. PubMed ID: 12236788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparation of hydrazino-modified proteins and their use for the synthesis of 99mTc-protein conjugates.
    Schwartz DA; Abrams MJ; Hauser MM; Gaul FE; Larsen SK; Rauh D; Zubieta JA
    Bioconjug Chem; 1991; 2(5):333-6. PubMed ID: 1838699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Technetium-99m labeling of murine monoclonal antibody fragments.
    Rhodes BA; Zamora PO; Newell KD; Valdez EF
    J Nucl Med; 1986 May; 27(5):685-93. PubMed ID: 3086522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thiolations, 99mTc labelings, and animal in vivo biodistributions of divalent monoclonal antibody fragments.
    Govindan SV; Goldenberg DM; Grebenau RC; Hansen HJ; Griffiths GL
    Bioconjug Chem; 1996; 7(3):290-7. PubMed ID: 8816950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preclinical evaluation of an "instant" 99mTc-labeling kit for antibody imaging.
    Hansen HJ; Jones AL; Sharkey RM; Grebenau R; Blazejewski N; Kunz A; Buckley MJ; Newman ES; Ostella F; Goldenberg DM
    Cancer Res; 1990 Feb; 50(3 Suppl):794s-798s. PubMed ID: 2297726
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reagents for astatination of biomolecules. 2. Conjugation of anionic boron cage pendant groups to a protein provides a method for direct labeling that is stable to in vivo deastatination.
    Wilbur DS; Chyan MK; Hamlin DK; Vessella RL; Wedge TJ; Hawthorne MF
    Bioconjug Chem; 2007; 18(4):1226-40. PubMed ID: 17583925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pyridine-containing 6-hydrazinonicotinamide derivatives as potential bifunctional chelators for 99mTc-labeling of small biomolecules.
    Purohit A; Liu S; Ellars CE; Casebier D; Haber SB; Edwards DS
    Bioconjug Chem; 2004; 15(4):728-37. PubMed ID: 15264859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.